Alembic

Alembic

Medical Devices, 627 National Avenue, Mountain View, California, 94043, United States, 11-50 Employees

alembicllc.com

  • LinkedIn

phone no Phone Number: 65********

Who is ALEMBIC

Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018. Palmera,...

Read More

map
  • 627 National Avenue, Mountain View, California, 94043, United States Headquarters: 627 National Avenue, Mountain View, California, 94043, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies
  • Aaron Berez CEO:   Aaron Berez

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ALEMBIC

Alembic Org Chart and Mapping

VP-Level

Mike Fourkas

VP Research and Development

Employees

Mary Koo

Office Manager/Accounting

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Alembic

Answer: Alembic's headquarters are located at 627 National Avenue, Mountain View, California, 94043, United States

Answer: Alembic's phone number is 65********

Answer: Alembic's official website is https://alembicllc.com

Answer: Alembic's revenue is $50 Million to $100 Million

Answer: Alembic's SIC: 3841

Answer: Alembic's NAICS: 339112

Answer: Alembic has 11-50 employees

Answer: Alembic is in Medical Devices

Answer: Alembic contact info: Phone number: 65******** Website: https://alembicllc.com

Answer: Cathera, Inc, the first Alembic portfolio company, developed the Phenom family of microcatheters optimized for intracranial navigation. Cathera was acquired by Medtronic in 2018. Palmera, Inc, a second Alembic portfolio company, is developing new therapeutic and novel products for the minimally invasive treatment of stroke that have the potential to improve outcome for patients that are currently treated, as well as widen the scope of patients that can benefit from therapy.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access